Simultaneous determination of docetaxel and ketoconazole in rat plasma by liquid chromatography/electrospray ionization tandem mass spectrometry

被引:33
作者
Huang, Qing
Wang, Guang-Ji [1 ]
Sun, Jian-Guo
Hu, Xiao-Lin
Lu, Yi-Hong
Zhang, Qian
机构
[1] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing 210038, Peoples R China
[2] Jiangsu Inst Drug Control, Nanjing 210008, Peoples R China
关键词
D O I
10.1002/rcm.2903
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid and sensitive liquid chromatography/tandem mass spectrometry (LC/MS/MS) method has been developed and validated for simultaneous quantification of docetaxel and ketoconazole in rat plasma with paclitaxel as internal standard (IS). The analytes were extracted from rat plasma by using a liquid-liquid extraction technique with ethyl acetate and the LC separation was performed on a Cosmosil-C-18 analytical column (150 mm x 2.0 mm i.d., Nacalai Tesque Inc., Japan). The extracted samples were analyzed with LC/MS/MS, operating in selected reaction monitoring (SRM) mode. The SRM transitions of precursor ions to product ions were 830.3 -> 549.1 (m/z) for docetaxel, 531.2 -> 489.3 (m/z) for ketoconazole, and 876.7 -> 307.9 (m/z) for the IS. The calibration curves were linear over the range of 2-500ng/mL for docetaxel and 50-20 000 ng/mL for ketoconazole, with coefficients of correlation above 0.999. The limits of quantification for docetaxel and ketoconazole were both 2 ng/mL. The limit of detection for each analyte was 1 ng/mL. The intra- and inter-day precision (CV) of analysis were within 7%, and the accuracy ranged from 95 to 110%. The overall recoveries for docetaxel and ketoconazole were about 89.0% and 91.1%, respectively. The total analysis time was only 9.0 min. This quantitation method was successfully applied to the simultaneous determination of docetaxel and ketoconazole in rat plasma and some potential interaction was found in the current coadministration pharmacokinetic study. This established method was also utilized in the in vitro and in vivo drug-drug interaction study of docetaxel and ketoconazole (to be published). Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:1009 / 1018
页数:10
相关论文
共 34 条
[1]  
Aapro M, 2001, ANTI-CANCER DRUG, V12, pS1
[2]  
Ardiet CJ, 1999, INVEST NEW DRUG, V17, P325
[3]  
Arlen Philip M, 2002, Clin Prostate Cancer, V1, P153, DOI 10.3816/CGC.2002.n.017
[4]  
Bardelmeijer HA, 2002, CANCER RES, V62, P6158
[5]  
BISSERY MC, 1991, CANCER RES, V51, P4845
[6]   Efficacy of microtubule-active drugs followed by ketoconazole in human metastatic prostate cancer cell lines [J].
Blagosklonny, MV ;
Dixon, SC ;
Figg, WD .
JOURNAL OF UROLOGY, 2000, 163 (03) :1022-1026
[7]   SIMPLIFIED BIOASSAY METHOD FOR MEASUREMENT OF FLUCYTOSINE OR KETOCONAZOLE [J].
BODET, CA ;
JORGENSEN, JH ;
DRUTZ, DJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (02) :157-160
[8]   DISPOSITION OF KETOCONAZOLE, AN ORAL ANTIFUNGAL, IN HUMANS [J].
BRASS, C ;
GALGIANI, JN ;
BLASCHKE, TF ;
DEFELICE, R ;
OREILLY, RA ;
STEVENS, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) :151-158
[9]   Determination of ketoconazole in human plasma by high-performance liquid chromatography - tandem mass spectrometry [J].
Chen, YL ;
Felder, L ;
Jiang, XY ;
Naidong, W .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 774 (01) :67-78
[10]   Clinical pharmacokinetics of docetaxel [J].
Clarke, SJ ;
Rivory, LP .
CLINICAL PHARMACOKINETICS, 1999, 36 (02) :99-114